marketcaparena

CI

Cigna Group

Company overview

Market capitalization
$71.83B
Employees
65,669
Latest publication
2026-09-29
About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USDQ3 20212021-09-30 · USDQ2 20212021-06-30 · USDQ1 20212021-03-31 · USDQ4 20202020-12-31 · USD
Total Revenue71,668,000,000USD72,472,000,000USD45,281,000,000USD45,478,000,000USD44,288,000,000USD43,131,000,000USD40,971,000,000USD41,712,000,000USD
Cost Of Revenue56,703,000,000USD66,918,000,000USD39,528,000,000USD39,342,000,000USD38,400,000,000USD37,485,000,000USD35,240,000,000USD35,906,000,000USD
Gross Profit14,965,000,000USD5,554,000,000USD5,753,000,000USD6,136,000,000USD5,888,000,000USD5,646,000,000USD5,731,000,000USD5,806,000,000USD
Selling General Administrative3,470,000,000USD3,406,000,000USD3,124,000,000USD3,256,000,000USD3,080,000,000USD2,996,000,000USD3,279,000,000USD3,398,000,000USD
Other Operating Expenses8,430,000,000USD———————
Total Operating Expenses12,289,000,000USD3,406,000,000USD3,611,000,000USD3,765,000,000USD3,594,000,000USD3,499,000,000USD3,774,000,000USD4,461,000,000USD
Operating Income2,676,000,000USD2,148,000,000USD2,142,000,000USD2,371,000,000USD2,294,000,000USD2,147,000,000USD1,957,000,000USD1,345,000,000USD
Total Other Income Expense Net-419,000,000USD-519,000,000USD1,349,000,000USD-390,000,000USD-235,000,000USD-249,000,000USD-444,000,000USD4,033,000,000USD
Interest Expense356,000,000USD335,000,000USD304,000,000USD301,000,000USD303,000,000USD298,000,000USD314,000,000USD337,000,000USD
Depreciation And Amortization389,000,000USD580,000,000USD726,000,000USD759,000,000USD734,000,000USD731,000,000USD715,000,000USD713,000,000USD
Income Before Tax2,257,000,000USD1,629,000,000USD3,491,000,000USD1,981,000,000USD2,059,000,000USD1,898,000,000USD1,513,000,000USD5,378,000,000USD
Income Tax Expense382,000,000USD395,000,000USD713,000,000USD411,000,000USD424,000,000USD422,000,000USD342,000,000USD1,236,000,000USD
Net Income1,875,000,000USD1,234,000,000USD2,757,000,000USD1,557,000,000USD1,621,000,000USD1,467,000,000USD1,161,000,000USD4,135,000,000USD
Minority Interest215,000,000USD-40,000,000USD21,000,000USD13,000,000USD14,000,000USD58,000,000USD10,000,000USD7,000,000USD
Net Income Applicable To Common Shares1,660,000,000USD1,234,000,000USD2,757,000,000USD1,559,000,000USD1,621,000,000USD1,467,000,000USD1,161,000,000USD4,135,000,000USD
Interest Income—462,000,000USD304,000,000USD301,000,000USD303,000,000USD298,000,000USD314,000,000USD337,000,000USD
Net Interest Income—-362,000,000USD-304,000,000USD-301,000,000USD-303,000,000USD-298,000,000USD-314,000,000USD-337,000,000USD
Tax Provision—543,000,000USD713,000,000USD413,000,000USD424,000,000USD422,000,000USD342,000,000USD1,236,000,000USD
Net Income From Continuing Ops—1,274,000,000USD2,778,000,000USD1,572,000,000USD1,635,000,000USD1,476,000,000USD1,171,000,000USD4,142,000,000USD
Ebit—1,964,000,000USD2,149,000,000USD2,384,000,000USD2,286,000,000USD2,143,000,000USD1,936,000,000USD1,517,000,000USD
Ebitda—2,544,000,000USD2,875,000,000USD3,143,000,000USD3,020,000,000USD2,874,000,000USD2,651,000,000USD2,230,000,000USD
Reconciled Depreciation—722,000,000USD726,000,000USD759,000,000USD734,000,000USD731,000,000USD715,000,000USD713,000,000USD
Unclassified Operating Expenses——487,000,000USD509,000,000USD514,000,000USD503,000,000USD495,000,000USD495,000,000USD
Non Operating Income Net Other——1,431,000,000USD-301,000,000USD-303,000,000USD-308,000,000USD-445,000,000USD3,866,000,000USD
Selling And Marketing Expenses———————568,000,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Total Revenue140,162,000,000USD
Cost Of Revenue110,803,000,000USD
Gross Profit29,359,000,000USD
Selling General Administrative7,192,000,000USD
Other Operating Expenses16,354,000,000USD
Total Operating Expenses24,325,000,000USD
Operating Income5,034,000,000USD
Total Other Income Expense Net-507,000,000USD
Interest Expense713,000,000USD
Depreciation And Amortization779,000,000USD
Income Before Tax4,527,000,000USD
Income Tax Expense791,000,000USD
Net Income3,736,000,000USD
Minority Interest422,000,000USD
Net Income Applicable To Common Shares3,314,000,000USD
SourceDisclosureDeterministicFinal

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USD
Total Revenue174,069,000,000USD160,401,000,000USD153,566,000,000USD48,650,000,000USD41,806,000,000USD37,876,000,000USD34,914,000,000USD32,380,000,000USD
Cost Of Revenue151,118,000,000USD136,194,000,000USD128,487,000,000USD32,321,000,000USD27,719,000,000USD25,424,000,000USD23,241,000,000USD28,382,000,000USD
Gross Profit22,951,000,000USD24,207,000,000USD25,079,000,000USD16,329,000,000USD14,087,000,000USD12,452,000,000USD11,673,000,000USD32,380,000,000USD
Selling General Administrative12,242,000,000USD14,072,000,000USD14,053,000,000USD11,934,000,000USD9,831,000,000USD9,750,000,000USD8,819,000,000USD7,566,000,000USD
Unclassified Operating Expenses2,768,000,000USD1,982,000,000USD2,949,000,000USD235,000,000USD314,000,000USD-9,658,000,000USD-8,734,000,000USD15,072,000,000USD
Total Operating Expenses15,010,000,000USD16,054,000,000USD17,002,000,000USD12,169,000,000USD10,145,000,000USD92,000,000USD85,000,000USD30,204,000,000USD
Operating Income7,941,000,000USD8,153,000,000USD8,077,000,000USD4,160,000,000USD3,942,000,000USD12,360,000,000USD11,588,000,000USD32,380,000,000USD
Interest Income1,208,000,000USD1,438,000,000USD1,682,000,000USD271,000,000USD252,000,000USD———
Interest Expense1,208,000,000USD1,438,000,000USD1,682,000,000USD498,000,000USD252,000,000USD0USD0USD264,000,000USD
Net Interest Income-1,208,000,000USD-1,438,000,000USD-1,682,000,000USD-498,000,000USD-252,000,000USD———
Income Before Tax6,790,000,000USD10,868,000,000USD6,570,000,000USD3,581,000,000USD3,606,000,000USD3,327,000,000USD3,304,000,000USD2,176,000,000USD
Income Tax Expense1,370,000,000USD2,379,000,000USD1,450,000,000USD935,000,000USD1,374,000,000USD1,250,000,000USD1,210,000,000USD698,000,000USD
Tax Provision1,367,000,000USD2,379,000,000USD1,450,000,000USD939,000,000USD1,142,000,000USD1,250,000,000USD——
Net Income5,370,000,000USD8,458,000,000USD5,104,000,000USD2,637,000,000USD2,237,000,000USD2,094,000,000USD2,102,000,000USD1,476,000,000USD
Net Income From Continuing Ops5,415,000,000USD8,489,000,000USD5,120,000,000USD2,646,000,000USD2,232,000,000USD2,077,000,000USD2,094,000,000USD—
Ebit8,162,000,000USD8,565,000,000USD8,815,000,000USD4,864,000,000USD4,126,000,000USD3,493,000,000USD3,304,000,000USD0USD
Ebitda9,963,000,000USD10,368,000,000USD11,582,000,000USD5,220,000,000USD4,376,000,000USD3,795,000,000USD3,620,000,000USD597,000,000USD
Depreciation And Amortization1,801,000,000USD1,803,000,000USD2,767,000,000USD356,000,000USD250,000,000USD302,000,000USD316,000,000USD597,000,000USD
Reconciled Depreciation2,923,000,000USD2,802,000,000USD3,651,000,000USD695,000,000USD566,000,000USD———
Total Other Income Expense Net-1,151,000,000USD2,715,000,000USD-1,507,000,000USD-579,000,000USD-336,000,000USD-9,033,000,000USD-8,284,000,000USD-30,204,000,000USD
Non Operating Income Net Other-1,349,000,000USD2,566,000,000USD-1,684,000,000USD-498,000,000USD————
Minority Interest50,000,000USD31,000,000USD41,000,000USD44,000,000USD49,000,000USD78,000,000USD105,000,000USD2,000,000USD
Net Income Applicable To Common Shares5,365,000,000USD8,458,000,000USD5,104,000,000USD2,637,000,000USD2,237,000,000USD2,094,000,000USD2,102,000,000USD1,476,000,000USD
Research Development———0USD0USD0USD0USD0USD
Selling And Marketing Expenses———————7,566,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets157,082,000,000USD153,266,000,000USD157,919,000,000USD157,919,000,000USD151,651,000,000USD150,658,000,000USD155,881,000,000USD157,639,000,000USD
Cash And Equivalents6,298,000,000USD—7,676,000,000USD6,025,000,000USD4,329,000,000USD8,334,000,000USD7,550,000,000USD5,888,000,000USD
Cash And Short Term Investments7,257,000,000USD7,852,000,000USD7,676,000,000USD6,908,000,000USD5,142,000,000USD9,061,000,000USD8,215,000,000USD6,752,000,000USD
Short Term Investments959,000,000USD812,000,000USD970,000,000USD883,000,000USD813,000,000USD727,000,000USD665,000,000USD864,000,000USD
Long Term Investments19,037,000,000USD12,260,000,000USD12,175,000,000USD12,144,000,000USD813,000,000USD727,000,000USD665,000,000USD864,000,000USD
Total Current Assets46,991,000,000USD43,032,000,000USD47,814,000,000USD46,735,000,000USD44,723,000,000USD43,555,000,000USD48,870,000,000USD49,222,000,000USD
Other Current Assets3,087,000,000USD2,742,000,000USD4,032,000,000USD2,486,000,000USD2,466,000,000USD3,080,000,000USD9,898,000,000USD9,541,000,000USD
Other Non Current Assets3,323,000,000USD———————
Total Liabilities114,172,000,000USD———————
Total Current Liabilities55,562,000,000USD52,606,000,000USD56,342,000,000USD56,453,000,000USD56,779,000,000USD55,745,000,000USD57,979,000,000USD57,060,000,000USD
Other Non Current Liabilities5,612,000,000USD———————
Total Stockholder Equity42,620,000,000USD42,210,000,000USD41,713,000,000USD41,805,000,000USD40,214,000,000USD40,226,000,000USD41,033,000,000USD42,095,000,000USD
Total Equity Including Noncontrolling Interest42,910,000,000USD———————
Long Term Debt29,086,000,000USD29,371,000,000USD30,871,000,000USD30,947,000,000USD26,480,000,000USD26,455,000,000USD28,937,000,000USD30,230,000,000USD
Net Receivables30,800,000,000USD26,607,000,000USD28,768,000,000USD31,709,000,000USD31,148,000,000USD26,238,000,000USD24,065,000,000USD27,846,000,000USD
Inventory5,847,000,000USD5,831,000,000USD7,338,000,000USD5,632,000,000USD5,967,000,000USD5,176,000,000USD6,692,000,000USD5,083,000,000USD
Property Plant Equipment Net3,736,000,000USD3,704,000,000USD3,651,000,000USD3,650,000,000USD3,621,000,000USD3,681,000,000USD828,000,000USD3,594,000,000USD
Goodwill45,534,000,000USD———————
Intangible Assets26,931,000,000USD27,318,000,000USD28,560,000,000USD28,975,000,000USD28,671,000,000USD29,045,000,000USD32,243,000,000USD29,791,000,000USD
Accounts Payable10,409,000,000USD35,642,000,000USD40,992,000,000USD39,647,000,000USD39,398,000,000USD37,736,000,000USD37,759,000,000USD37,316,000,000USD
Short Term Debt2,792,000,000USD1,529,000,000USD592,000,000USD3,093,000,000USD4,288,000,000USD3,993,000,000USD3,035,000,000USD2,572,000,000USD
Common Stock4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD
Retained Earnings50,355,000,000USD49,106,000,000USD47,865,000,000USD47,028,000,000USD45,564,000,000USD44,434,000,000USD43,519,000,000USD42,480,000,000USD
Accumulated Other Comprehensive Income-4,361,000,000USD-3,598,000,000USD-2,806,000,000USD-2,799,000,000USD-2,816,000,000USD-2,590,000,000USD-2,341,000,000USD-2,163,000,000USD
Total Liab—110,824,000,000USD116,045,000,000USD115,905,000,000USD111,221,000,000USD110,244,000,000USD114,638,000,000USD115,341,000,000USD
Other Current Liab—15,435,000,000USD14,758,000,000USD13,713,000,000USD13,093,000,000USD14,016,000,000USD17,185,000,000USD17,172,000,000USD
Capital Stock—4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD
Good Will—45,534,000,000USD44,924,000,000USD44,924,000,000USD44,375,000,000USD44,372,000,000USD44,370,000,000USD44,374,000,000USD
Cash—7,040,000,000USD7,676,000,000USD6,025,000,000USD4,329,000,000USD8,334,000,000USD7,550,000,000USD5,888,000,000USD
Net Debt—23,860,000,000USD23,787,000,000USD28,015,000,000USD26,439,000,000USD22,114,000,000USD24,422,000,000USD26,914,000,000USD
Short Long Term Debt—1,529,000,000USD592,000,000USD3,093,000,000USD4,288,000,000USD3,993,000,000USD3,035,000,000USD2,572,000,000USD
Short Long Term Debt Total—30,900,000,000USD31,463,000,000USD34,040,000,000USD30,768,000,000USD30,448,000,000USD31,972,000,000USD32,802,000,000USD
Common Stock Shares Outstanding—264,217,252shares265,948,276shares268,154,000shares268,154,000shares283,218,000shares277,784,000shares281,396,000shares
Non Current Assets Total—110,234,000,000USD110,105,000,000USD111,184,000,000USD106,928,000,000USD107,103,000,000USD107,011,000,000USD108,417,000,000USD
Non Current Liabilities Total—58,218,000,000USD59,703,000,000USD59,452,000,000USD54,442,000,000USD54,499,000,000USD56,659,000,000USD58,281,000,000USD
Non Current Liabilities Other—12,219,000,000USD11,749,000,000USD11,429,000,000USD11,024,000,000USD10,856,000,000USD——
Non Currrent Assets Other—14,776,000,000USD14,499,000,000USD15,152,000,000USD14,599,000,000USD14,655,000,000USD14,442,000,000USD15,388,000,000USD
Net Working Capital—-9,574,000,000USD-8,528,000,000USD-9,718,000,000USD-12,056,000,000USD-12,190,000,000USD——
Unclassified Non Current Assets—6,642,000,000USD-8,203,000,000USD-8,813,000,000USD-132,505,000,000USD—-141,418,000,000USD14,406,000,000USD
Unclassified Current Liabilities—-1,529,000,000USD-592,000,000USD-3,093,000,000USD-4,288,000,000USD-3,993,000,000USD-3,035,000,000USD-2,572,000,000USD
Unclassified Non Current Liabilities—16,628,000,000USD17,083,000,000USD17,076,000,000USD16,938,000,000USD17,188,000,000USD27,722,000,000USD28,051,000,000USD
Unclassified Equity—-3,306,000,000USD-3,354,000,000USD-2,432,000,000USD-2,542,000,000USD-1,626,000,000USD—1,770,000,000USD
Other Assets——14,499,000,000USD15,152,000,000USD147,354,000,000USD14,655,000,000USD155,881,000,000USD-4,557,000,000USD
Property Plant Equipment Gross——13,753,000,000USD—————
Unclassified Current Assets——-970,000,000USD—————
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets157,919,000,000USD155,881,000,000USD152,761,000,000USD143,885,000,000USD154,889,000,000USD155,451,000,000USD155,774,000,000USD153,226,000,000USD
Intangible Assets28,560,000,000USD32,243,000,000USD33,681,000,000USD35,340,000,000USD36,911,000,000USD38,192,000,000USD39,763,000,000USD42,282,000,000USD
Other Current Assets4,032,000,000USD9,898,000,000USD5,509,000,000USD1,546,000,000USD11,796,000,000USD1,122,000,000USD11,246,000,000USD1,512,000,000USD
Total Liab116,045,000,000USD114,638,000,000USD106,410,000,000USD98,981,000,000USD107,705,000,000USD105,065,000,000USD110,395,000,000USD112,154,000,000USD
Total Stockholder Equity41,713,000,000USD41,033,000,000USD46,223,000,000USD44,872,000,000USD47,112,000,000USD50,321,000,000USD45,338,000,000USD41,028,000,000USD
Other Current Liab45,091,000,000USD17,185,000,000USD17,573,000,000USD13,273,000,000USD18,904,000,000USD13,671,000,000USD18,914,000,000USD13,872,000,000USD
Common Stock4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD
Capital Stock4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD4,000,000USD
Retained Earnings47,865,000,000USD43,519,000,000USD41,652,000,000USD37,874,000,000USD32,593,000,000USD28,575,000,000USD20,162,000,000USD15,088,000,000USD
Good Will44,924,000,000USD44,370,000,000USD44,259,000,000USD45,811,000,000USD45,811,000,000USD44,648,000,000USD44,602,000,000USD44,505,000,000USD
Other Assets14,499,000,000USD14,442,000,000USD4,835,000,000USD32,160,000,000USD43,965,000,000USD41,184,000,000USD47,884,000,000USD65,156,000,000USD
Cash7,676,000,000USD7,550,000,000USD7,822,000,000USD5,924,000,000USD5,081,000,000USD10,182,000,000USD4,619,000,000USD3,855,000,000USD
Cash And Equivalents7,676,000,000USD7,550,000,000USD7,822,000,000USD5,924,000,000USD5,081,000,000USD10,182,000,000USD4,619,000,000USD3,855,000,000USD
Cash And Short Term Investments7,676,000,000USD8,215,000,000USD8,747,000,000USD6,829,000,000USD6,001,000,000USD11,513,000,000USD5,556,000,000USD5,900,000,000USD
Total Current Assets47,814,000,000USD48,870,000,000USD37,351,000,000USD30,122,000,000USD36,134,000,000USD27,799,000,000USD29,845,000,000USD20,430,000,000USD
Total Current Liabilities56,342,000,000USD57,979,000,000USD48,716,000,000USD41,225,000,000USD43,572,000,000USD36,022,000,000USD40,138,000,000USD31,895,000,000USD
Net Debt23,787,000,000USD24,422,000,000USD23,108,000,000USD25,629,000,000USD29,184,000,000USD23,380,000,000USD33,419,000,000USD38,623,000,000USD
Short Term Debt592,000,000USD3,035,000,000USD2,775,000,000USD3,107,000,000USD2,704,000,000USD3,526,000,000USD5,680,000,000USD2,955,000,000USD
Short Long Term Debt592,000,000USD3,035,000,000USD2,775,000,000USD2,993,000,000USD2,545,000,000USD3,374,000,000USD5,514,000,000USD2,955,000,000USD
Short Long Term Debt Total31,463,000,000USD31,972,000,000USD30,930,000,000USD31,553,000,000USD34,265,000,000USD33,562,000,000USD38,038,000,000USD42,478,000,000USD
Long Term Debt30,871,000,000USD28,937,000,000USD28,155,000,000USD28,034,000,000USD31,097,000,000USD29,545,000,000USD31,832,000,000USD39,523,000,000USD
Long Term Investments12,175,000,000USD665,000,000USD925,000,000USD16,288,000,000USD18,438,000,000USD23,262,000,000USD937,000,000USD2,045,000,000USD
Short Term Investments970,000,000USD665,000,000USD925,000,000USD905,000,000USD920,000,000USD1,331,000,000USD937,000,000USD2,045,000,000USD
Net Receivables28,768,000,000USD24,065,000,000USD17,450,000,000USD16,970,000,000USD14,615,000,000USD11,999,000,000USD10,382,000,000USD10,197,000,000USD
Inventory7,338,000,000USD6,692,000,000USD5,645,000,000USD4,777,000,000USD3,722,000,000USD3,165,000,000USD2,661,000,000USD2,821,000,000USD
Accounts Payable10,659,000,000USD37,759,000,000USD28,368,000,000USD24,845,000,000USD21,964,000,000USD18,825,000,000USD15,544,000,000USD15,068,000,000USD
Property Plant Equipment Net3,651,000,000USD828,000,000USD877,000,000USD1,301,000,000USD1,664,000,000USD1,744,000,000USD1,752,000,000USD1,283,000,000USD
Property Plant Equipment Gross13,753,000,000USD13,108,000,000USD12,261,000,000USD11,204,000,000USD—4,205,000,000USD4,417,000,000USD4,562,000,000USD
Accumulated Other Comprehensive Income-2,806,000,000USD-2,341,000,000USD-1,864,000,000USD-1,395,000,000USD-884,000,000USD-861,000,000USD-941,000,000USD-1,711,000,000USD
Common Stock Shares Outstanding265,948,000shares283,218,000shares296,882,000shares313,065,000shares340,966,000shares368,389,000shares379,817,000shares246,652,000shares
Non Current Assets Total110,105,000,000USD107,011,000,000USD115,410,000,000USD113,763,000,000USD118,755,000,000USD127,652,000,000USD125,929,000,000USD132,796,000,000USD
Non Current Liabilities Total59,703,000,000USD56,659,000,000USD57,694,000,000USD57,906,000,000USD64,133,000,000USD69,043,000,000USD70,257,000,000USD80,259,000,000USD
Non Current Liabilities Other11,749,000,000USD10,493,000,000USD10,871,000,000USD21,901,000,000USD24,662,000,000USD30,559,000,000USD28,977,000,000USD31,283,000,000USD
Non Currrent Assets Other14,499,000,000USD14,442,000,000USD18,608,000,000USD15,075,000,000USD15,973,000,000USD19,869,000,000USD18,319,000,000USD17,797,000,000USD
Net Working Capital-8,528,000,000USD-9,109,000,000USD-11,365,000,000USD-11,103,000,000USD————
Unclassified Current Assets-970,000,000USD———————
Unclassified Non Current Assets-8,203,000,000USD—12,225,000,000USD-32,212,000,000USD-44,007,000,000USD-41,247,000,000USD-27,328,000,000USD-40,272,000,000USD
Unclassified Current Liabilities-592,000,000USD-3,035,000,000USD-2,775,000,000USD-2,993,000,000USD-2,545,000,000USD-3,374,000,000USD-5,514,000,000USD-2,955,000,000USD
Unclassified Non Current Liabilities17,083,000,000USD17,229,000,000USD18,668,000,000USD-29,086,000,000USD-32,980,000,000USD-39,498,000,000USD-37,838,000,000USD-40,736,000,000USD
Unclassified Equity-3,354,000,000USD—6,427,000,000USD30,229,000,000USD29,570,000,000USD28,971,000,000USD28,302,000,000USD27,747,000,000USD
Deferred Long Term Liab———7,751,000,000USD8,346,000,000USD8,939,000,000USD9,387,000,000USD9,453,000,000USD
Other Liab———29,306,000,000USD33,008,000,000USD39,498,000,000USD37,899,000,000USD40,736,000,000USD
Treasury Stock———-21,844,000,000USD-14,175,000,000USD-6,372,000,000USD-2,193,000,000USD-104,000,000USD
Net Tangible Assets———-33,365,000,000USD-32,801,000,000USD-29,448,000,000USD-35,826,000,000USD-45,759,000,000USD
Current Deferred Revenue———————-24,574,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Net Income3,736,000,000USD
Depreciation1,305,000,000USD
Deferred Income Tax-170,000,000USD
Other Non Cash Items-206,000,000USD
Unclassified Operating Cash Flow-429,000,000USD
Change To Account Receivables-2,044,000,000USD
Change To Inventory1,490,000,000USD
Change To Liabilities-2,972,000,000USD
Change In Working Capital-3,955,000,000USD
Operating Cash Flow710,000,000USD
Capital Expenditures-564,000,000USD
Net Investments-366,000,000USD
Other Investing Activities-22,000,000USD
Unclassified Investing Cash Flow-188,000,000USD
Investing Cash Flow-1,140,000,000USD
Net Debt Issuance425,000,000USD
Common Stock Issuance158,000,000USD
Net Common Stock Issuance-122,000,000USD
Common Dividends Paid-826,000,000USD
Other Financing Activities-327,000,000USD
Unclassified Financing Cash Flow-84,000,000USD
Financing Cash Flow-934,000,000USD
Effect Of Forex Changes On Cash-16,000,000USD
Change In Cash-1,380,000,000USD
End Cash Flow6,356,000,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
Net Income1,861,000,000USD1,868,000,000USD1,632,000,000USD1,409,000,000USD1,536,000,000USD825,000,000USD1,629,000,000USD-212,000,000USD
Depreciation650,000,000USD697,000,000USD682,000,000USD674,000,000USD646,000,000USD650,000,000USD738,000,000USD741,000,000USD
Other Non Cash Items43,000,000USD-76,000,000USD-52,000,000USD-39,000,000USD-198,000,000USD1,008,000,000USD48,000,000USD1,855,000,000USD
Change To Account Receivables2,152,000,000USD-111,000,000USD-4,376,000,000USD-2,424,000,000USD3,104,000,000USD-3,086,000,000USD-5,253,000,000USD-2,619,000,000USD
Change To Inventory1,507,000,000USD1,060,000,000USD726,000,000USD1,517,000,000USD—105,000,000USD-543,000,000USD1,015,000,000USD
Change In Working Capital-1,363,000,000USD811,000,000USD-4,072,000,000USD92,000,000USD2,972,000,000USD-2,285,000,000USD-2,053,000,000USD2,558,000,000USD
Total Cash From Operating Activities1,131,000,000USD3,418,000,000USD-1,886,000,000USD1,920,000,000USD5,212,000,000USD46,000,000USD265,000,000USD4,840,000,000USD
Capital Expenditures-267,000,000USD-278,000,000USD-285,000,000USD-327,000,000USD-337,000,000USD-399,000,000USD-370,000,000USD-300,000,000USD
Free Cash Flow864,000,000USD3,140,000,000USD-2,171,000,000USD1,593,000,000USD4,875,000,000USD-353,000,000USD-105,000,000USD4,540,000,000USD
Investments-254,000,000USD-4,387,000,000USD-797,000,000USD1,197,000,000USD-191,000,000USD-776,000,000USD-640,000,000USD-495,000,000USD
Total Cashflows From Investing Activities-637,000,000USD-4,387,000,000USD-797,000,000USD1,197,000,000USD-191,000,000USD-776,000,000USD-640,000,000USD-495,000,000USD
Net Borrowings-563,000,000USD3,206,000,000USD287,000,000USD-1,591,000,000USD-768,000,000USD833,000,000USD——
Total Cash From Financing Activities-1,141,000,000USD2,659,000,000USD-1,333,000,000USD-3,681,000,000USD-3,248,000,000USD439,000,000USD-2,309,000,000USD-2,529,000,000USD
Dividends Paid-417,000,000USD-402,000,000USD-401,000,000USD-412,000,000USD-384,000,000USD-390,000,000USD-392,000,000USD-401,000,000USD
Sale Purchase Of Stock0USD-2,442,000,000USD-1,112,000,000USD-1,508,000,000USD-2,022,000,000USD-4,729,000,000USD-990,000,000USD-4,022,000,000USD
Issuance Of Capital Stock57,000,000USD37,000,000USD72,000,000USD69,000,000USD22,000,000USD62,000,000USD40,000,000USD181,000,000USD
Change In Cash-656,000,000USD1,696,000,000USD-3,990,000,000USD-555,000,000USD1,747,000,000USD-273,000,000USD-2,687,000,000USD1,807,000,000USD
Begin Period Cash Flow7,736,000,000USD4,329,000,000USD8,376,000,000USD8,931,000,000USD7,184,000,000USD7,457,000,000USD10,144,000,000USD8,337,000,000USD
End Period Cash Flow7,080,000,000USD6,025,000,000USD4,386,000,000USD8,376,000,000USD8,931,000,000USD7,184,000,000USD7,457,000,000USD10,144,000,000USD
Other Cashflows From Investing Activities-136,000,000USD-2,839,000,000USD-275,000,000USD-42,000,000USD-378,000,000USD-95,000,000USD-225,000,000USD-140,000,000USD
Other Cashflows From Financing Activities-218,000,000USD-183,000,000USD-179,000,000USD-239,000,000USD-96,000,000USD-66,000,000USD-74,000,000USD-175,000,000USD
Unclassified Operating Cash Flow-60,000,000USD118,000,000USD-76,000,000USD-216,000,000USD—-152,000,000USD-97,000,000USD-102,000,000USD
Unclassified Investing Cash Flow20,000,000USD3,117,000,000USD560,000,000USD369,000,000USD715,000,000USD494,000,000USD595,000,000USD440,000,000USD
Unclassified Financing Cash Flow57,000,000USD2,480,000,000USD72,000,000USD69,000,000USD—4,791,000,000USD-853,000,000USD2,069,000,000USD
Stock Based Compensation————308,000,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income6,288,000,000USD3,778,000,000USD5,372,000,000USD6,782,000,000USD5,420,000,000USD8,489,000,000USD5,120,000,000USD2,646,000,000USD
Depreciation2,775,000,000USD2,775,000,000USD3,035,000,000USD2,937,000,000USD2,923,000,000USD2,802,000,000USD3,651,000,000USD695,000,000USD
Other Non Cash Items473,000,000USD2,713,000,000USD1,577,000,000USD-1,175,000,000USD-57,000,000USD-4,153,000,000USD-175,000,000USD81,000,000USD
Change To Account Receivables-4,630,000,000USD-7,854,000,000USD-2,202,000,000USD-1,844,000,000USD-3,498,000,000USD-1,573,000,000USD-990,000,000USD471,000,000USD
Change To Inventory-646,000,000USD-1,032,000,000USD-868,000,000USD-1,055,000,000USD143,000,000USD30,000,000USD149,000,000USD216,000,000USD
Change In Working Capital-261,000,000USD1,192,000,000USD3,488,000,000USD584,000,000USD-879,000,000USD3,598,000,000USD1,202,000,000USD449,000,000USD
Total Cash From Operating Activities9,601,000,000USD10,363,000,000USD11,813,000,000USD8,656,000,000USD7,191,000,000USD10,350,000,000USD9,485,000,000USD3,770,000,000USD
Capital Expenditures-1,212,000,000USD-1,406,000,000USD-1,573,000,000USD-1,295,000,000USD-1,154,000,000USD-1,094,000,000USD-1,050,000,000USD-528,000,000USD
Free Cash Flow8,389,000,000USD8,957,000,000USD10,240,000,000USD7,361,000,000USD6,037,000,000USD9,256,000,000USD8,435,000,000USD3,242,000,000USD
Investments-4,552,000,000USD-2,102,000,000USD-5,174,000,000USD-587,000,000USD-765,000,000USD-443,000,000USD-4,832,000,000USD-1,383,000,000USD
Total Cashflows From Investing Activities-4,407,000,000USD-2,102,000,000USD-5,174,000,000USD3,098,000,000USD-3,611,000,000USD2,976,000,000USD-734,000,000USD-26,378,000,000USD
Net Borrowings-667,000,000USD1,060,000,000USD-278,000,000USD-500,000,000USD800,000,000USD-4,796,000,000USD-5,175,000,000USD24,212,000,000USD
Total Cash From Financing Activities-6,421,000,000USD-7,647,000,000USD-4,294,000,000USD-11,240,000,000USD-8,212,000,000USD-8,533,000,000USD-7,187,000,000USD23,515,000,000USD
Dividends Paid-1,611,000,000USD-1,567,000,000USD-1,450,000,000USD-1,384,000,000USD-1,341,000,000USD-15,000,000USD-15,000,000USD-24,343,000,000USD
Sale Purchase Of Stock-3,621,000,000USD-7,034,000,000USD-2,284,000,000USD-7,607,000,000USD-7,742,000,000USD-4,042,000,000USD-1,987,000,000USD-342,000,000USD
Issuance Of Capital Stock203,000,000USD305,000,000USD185,000,000USD389,000,000USD326,000,000USD376,000,000USD224,000,000USD68,000,000USD
Change In Cash126,000,000USD594,000,000USD2,361,000,000USD428,000,000USD-4,697,000,000USD4,834,000,000USD1,556,000,000USD883,000,000USD
Begin Period Cash Flow7,550,000,000USD8,337,000,000USD5,976,000,000USD5,548,000,000USD10,245,000,000USD5,411,000,000USD3,855,000,000USD2,972,000,000USD
End Period Cash Flow7,676,000,000USD8,931,000,000USD8,337,000,000USD5,976,000,000USD5,548,000,000USD10,245,000,000USD5,411,000,000USD3,855,000,000USD
Other Cashflows From Investing Activities-1,030,000,000USD-838,000,000USD-264,000,000USD-233,000,000USD-50,000,000USD-71,000,000USD-119,000,000USD-109,000,000USD
Other Cashflows From Financing Activities-726,000,000USD-411,000,000USD-469,000,000USD-79,000,000USD-112,000,000USD-328,000,000USD-237,000,000USD-423,000,000USD
Unclassified Operating Cash Flow326,000,000USD-403,000,000USD-1,945,000,000USD-736,000,000USD-484,000,000USD-675,000,000USD-612,000,000USD-281,000,000USD
Unclassified Investing Cash Flow2,387,000,000USD2,244,000,000USD1,837,000,000USD5,213,000,000USD-1,642,000,000USD4,584,000,000USD5,267,000,000USD-24,358,000,000USD
Unclassified Financing Cash Flow204,000,000USD305,000,000USD187,000,000USD-1,670,000,000USD183,000,000USD648,000,000USD227,000,000USD24,411,000,000USD
Stock Based Compensation—308,000,000USD286,000,000USD264,000,000USD268,000,000USD289,000,000USD299,000,000USD180,000,000USD
Change To Liabilities———1,865,000,000USD-77,000,000USD2,187,000,000USD1,918,000,000USD892,000,000USD
Cash And Cash Equivalents Changes———514,000,000USD-4,632,000,000USD4,793,000,000USD1,564,000,000USD883,000,000USD
Exchange Rate Changes———————-24,000,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

Adjusted Income from Operations

Period endPeriodValueUnitSource
2026-06-30quarterly2,054,000,000USDDisclosure

Cigna Healthcare Medical Care Ratio

Period endPeriodValueUnitSource
2026-06-30quarterly84.5percentDisclosure

Cigna Healthcare SG&A Expense Ratio

Period endPeriodValueUnitSource
2026-06-30quarterly19.6percentDisclosure

Evernorth Health Services SG&A Expense Ratio

Period endPeriodValueUnitSource
2026-06-30quarterly1.7percentDisclosure

International Health Administrative-Services-Only Medical Customers

Period endPeriodValueUnitSource
2026-06-30instant473thousand customersDisclosure

International Health Insured Medical Customers

Period endPeriodValueUnitSource
2026-06-30instant1,262thousand customersDisclosure

Pharmacy Claim Volume

Period endPeriodValueUnitSource
2026-06-30quarterly537million adjusted claimsDisclosure

Total Administrative-Services-Only Medical Customers

Period endPeriodValueUnitSource
2026-06-30instant14,712thousand customersDisclosure

Total Cigna Healthcare Medical Customers

Period endPeriodValueUnitSource
2026-06-30instant18,413thousand customersDisclosure

Total Insured Medical Customers

Period endPeriodValueUnitSource
2026-06-30instant3,701thousand customersDisclosure

U.S. Healthcare Administrative-Services-Only Medical Customers

Period endPeriodValueUnitSource
2026-06-30instant14,239thousand customersDisclosure

U.S. Healthcare Insured Medical Customers

Period endPeriodValueUnitSource
2026-06-30instant2,439thousand customersDisclosure

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2026Quarterly · 2026-06-30ProductProduct57,172,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductService Fees And Other Revenues9,816,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductService Other315,000,000USDDisclosure
Q2 2026Quarterly · 2026-06-30ProductServices4,365,000,000USDDisclosure
Q1 2026Quarterly · 2026-03-31ProductProduct54,037,000,000USD0001739940-26-000043
Q1 2026Quarterly · 2026-03-31ProductService Fees And Other Revenues9,855,000,000USD0001739940-26-000043
Q1 2026Quarterly · 2026-03-31ProductService Other159,000,000USD0001739940-26-000043
Q1 2026Quarterly · 2026-03-31ProductServices4,443,000,000USD0001739940-26-000043
Q4 2025Quarterly · 2025-12-31ProductProduct58,336,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductService Fees And Other Revenues9,483,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductService Other144,000,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductServices4,509,000,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductProduct216,672,000,000USD0001739940-26-000006
FY 2025Yearly · 2025-12-31ProductService Fees And Other Revenues40,611,000,000USD0001739940-26-000006
FY 2025Yearly · 2025-12-31ProductService Other696,000,000USD0001739940-26-000006
FY 2025Yearly · 2025-12-31ProductServices16,921,000,000USD0001739940-26-000006
Q3 2025Quarterly · 2025-09-30ProductProduct56,054,000,000USD0001739940-25-000037
Q3 2025Quarterly · 2025-09-30ProductService Fees And Other Revenues9,038,000,000USD0001739940-25-000037
Q3 2025Quarterly · 2025-09-30ProductService Other276,000,000USD0001739940-25-000037
Q3 2025Quarterly · 2025-09-30ProductServices4,380,000,000USD0001739940-25-000037
Q2 2025Quarterly · 2025-06-30ProductProduct53,649,000,000USD0001739940-25-000028
Q2 2025Quarterly · 2025-06-30ProductService Fees And Other Revenues9,278,000,000USD0001739940-25-000028
Q2 2025Quarterly · 2025-06-30ProductService Other114,000,000USD0001739940-25-000028
Q2 2025Quarterly · 2025-06-30ProductServices4,137,000,000USD0001739940-25-000028
Q1 2025Quarterly · 2025-03-31ProductProduct48,633,000,000USD0001739940-26-000043
Q1 2025Quarterly · 2025-03-31ProductService Fees And Other Revenues12,812,000,000USD0001739940-26-000043
Q1 2025Quarterly · 2025-03-31ProductService Other162,000,000USD0001739940-26-000043
Q1 2025Quarterly · 2025-03-31ProductServices3,895,000,000USD0001739940-26-000043
Q4 2024Quarterly · 2024-12-31ProductProduct49,941,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductService Fees And Other Revenues11,705,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductService Other75,000,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductServices3,928,000,000USDLegacy provider
FY 2024Yearly · 2024-12-31ProductProduct185,362,000,000USD0001739940-26-000006
FY 2024Yearly · 2024-12-31ProductService Fees And Other Revenues46,385,000,000USD0001739940-26-000006
FY 2024Yearly · 2024-12-31ProductService Other584,000,000USD0001739940-26-000006
FY 2024Yearly · 2024-12-31ProductServices14,790,000,000USD0001739940-26-000006
Q3 2024Quarterly · 2024-09-30ProductProduct48,284,000,000USD0001739940-25-000037
Q3 2024Quarterly · 2024-09-30ProductService Fees And Other Revenues11,254,000,000USD0001739940-25-000037
Q3 2024Quarterly · 2024-09-30ProductService Other267,000,000USD0001739940-25-000037
Q3 2024Quarterly · 2024-09-30ProductServices3,889,000,000USD0001739940-25-000037
FY 2023Yearly · 2023-12-31ProductProduct137,243,000,000USD0001739940-26-000006
FY 2023Yearly · 2023-12-31ProductService Fees And Other Revenues45,193,000,000USD0001739940-26-000006
FY 2023Yearly · 2023-12-31ProductService Other210,000,000USD0001739940-26-000006
FY 2023Yearly · 2023-12-31ProductServices12,619,000,000USD0001739940-26-000006
FY 2022Yearly · 2022-12-31ProductProduct128,566,000,000USD0001739940-25-000009
FY 2022Yearly · 2022-12-31ProductService Fees And Other Revenues40,903,000,000USD0001739940-25-000009
FY 2022Yearly · 2022-12-31ProductService Other168,000,000USD0001739940-25-000009
FY 2022Yearly · 2022-12-31ProductServices10,881,000,000USD0001739940-25-000009
Q3 2021Quarterly · 2021-09-30SegmentEvernorth33,614,000,000USD0001739940-21-000024
Q3 2021Quarterly · 2021-09-30SegmentGroup Disability And Other140,000,000USD0001739940-21-000024
Q3 2021Quarterly · 2021-09-30SegmentUSMedical10,497,000,000USD0001739940-21-000024
Q2 2021Quarterly · 2021-06-30SegmentEvernorth32,592,000,000USD0001739940-21-000017
Q2 2021Quarterly · 2021-06-30SegmentGroup Disability And Other129,000,000USD0001739940-21-000017
Q2 2021Quarterly · 2021-06-30SegmentUSMedical10,456,000,000USD0001739940-21-000017
Q1 2021Quarterly · 2021-03-31SegmentEvernorth30,620,000,000USD0001739940-21-000011
Q1 2021Quarterly · 2021-03-31SegmentGroup Disability And Other139,000,000USD0001739940-21-000011
Q1 2021Quarterly · 2021-03-31SegmentUSMedical10,362,000,000USD0001739940-21-000011
Q4 2020Quarterly · 2020-12-31SegmentEvernorth30,533,000,000USDLegacy provider
Q4 2020Quarterly · 2020-12-31SegmentGroup Disability And Other1,469,000,000USDLegacy provider
Q4 2020Quarterly · 2020-12-31SegmentUSMedical9,725,000,000USDLegacy provider
FY 2020Yearly · 2020-12-31SegmentEvernorth116,334,000,000USD0001739940-21-000007
FY 2020Yearly · 2020-12-31SegmentGroup Disability And Other5,616,000,000USD0001739940-21-000007
FY 2020Yearly · 2020-12-31SegmentUSMedical38,451,000,000USD0001739940-21-000007
Q3 2020Quarterly · 2020-09-30SegmentEvernorth29,944,000,000USD0001739940-21-000024
Q3 2020Quarterly · 2020-09-30SegmentGroup Disability And Other1,382,000,000USD0001739940-21-000024
Q3 2020Quarterly · 2020-09-30SegmentUSMedical9,629,000,000USD0001739940-21-000024
Q2 2020Quarterly · 2020-06-30SegmentEvernorth28,602,000,000USD0001739940-21-000017
Q2 2020Quarterly · 2020-06-30SegmentGroup Disability And Other1,426,000,000USD0001739940-21-000017
Q2 2020Quarterly · 2020-06-30SegmentUSMedical9,237,000,000USD0001739940-21-000017
Q1 2020Quarterly · 2020-03-31SegmentEvernorth27,255,000,000USD0001739940-21-000011
Q1 2020Quarterly · 2020-03-31SegmentGroup Disability And Other1,339,000,000USD0001739940-21-000011
Q1 2020Quarterly · 2020-03-31SegmentUSMedical9,860,000,000USD0001739940-21-000011
Q4 2019Quarterly · 2019-12-31SegmentGroup Disability And Other1,777,000,000USDLegacy provider
Q4 2019Quarterly · 2019-12-31SegmentHealth Services27,260,000,000USDLegacy provider
Q4 2019Quarterly · 2019-12-31SegmentIntegrated Medical9,208,000,000USDLegacy provider
FY 2019Yearly · 2019-12-31SegmentEvernorth109,794,000,000USD0001739940-21-000007
FY 2019Yearly · 2019-12-31SegmentGroup Disability And Other7,253,000,000USD0001739940-21-000007
FY 2019Yearly · 2019-12-31SegmentUSMedical36,519,000,000USD0001739940-21-000007
FY 2018Yearly · 2018-12-31SegmentEvernorth7,065,000,000USD0001739940-21-000007
FY 2018Yearly · 2018-12-31SegmentGroup Disability And Other8,794,000,000USD0001739940-21-000007
FY 2018Yearly · 2018-12-31SegmentUSMedical32,791,000,000USD0001739940-21-000007
FY 2017Yearly · 2017-12-31SegmentAll Other Segments463,000,000USD0001047469-18-001158
FY 2017Yearly · 2017-12-31SegmentGlobal Health Benefits32,753,000,000USD0001047469-18-001158
FY 2017Yearly · 2017-12-31SegmentGlobal Supplemental Benefits3,904,000,000USD0001047469-18-001158
FY 2017Yearly · 2017-12-31SegmentGroup Disability And Life4,515,000,000USD0001047469-18-001158
FY 2016Yearly · 2016-12-31SegmentAll Other Segments467,000,000USD0001047469-18-001158
FY 2016Yearly · 2016-12-31SegmentGlobal Health Benefits31,318,000,000USD0001047469-18-001158
FY 2016Yearly · 2016-12-31SegmentGlobal Supplemental Benefits3,380,000,000USD0001047469-18-001158
FY 2016Yearly · 2016-12-31SegmentGroup Disability And Life4,502,000,000USD0001047469-18-001158
FY 2015Yearly · 2015-12-31SegmentAll Other Segments494,000,000USD0001047469-18-001158
FY 2015Yearly · 2015-12-31SegmentGlobal Health Benefits29,972,000,000USD0001047469-18-001158
FY 2015Yearly · 2015-12-31SegmentGlobal Supplemental Benefits3,149,000,000USD0001047469-18-001158
FY 2015Yearly · 2015-12-31SegmentGroup Disability And Life4,276,000,000USD0001047469-18-001158
FY 2014Yearly · 2014-12-31SegmentAll Other Segments525,000,000USD0001047469-17-000899
FY 2014Yearly · 2014-12-31SegmentGlobal Health Benefits27,369,000,000USD0001047469-17-000899
FY 2014Yearly · 2014-12-31SegmentGlobal Supplemental Benefits3,008,000,000USD0001047469-17-000899
FY 2014Yearly · 2014-12-31SegmentGroup Disability And Life3,992,000,000USD0001047469-17-000899
FY 2013Yearly · 2013-12-31SegmentCorporate-37,000,000USD0001047469-14-001502
FY 2013Yearly · 2013-12-31SegmentGlobal Health Benefits25,296,000,000USD0001047469-14-001502
FY 2013Yearly · 2013-12-31SegmentGlobal Supplemental Benefits2,639,000,000USD0001047469-14-001502

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.